SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-19-280628
Filing Date
2019-10-31
Accepted
2019-10-31 17:27:48
Documents
4
Effectiveness Date
2019-10-31

Document Format Files

Seq Description Document Type Size
1 S-8 d813820ds8.htm S-8 75870
2 EX-5.1 d813820dex51.htm EX-5.1 6399
3 EX-23.1 d813820dex231.htm EX-23.1 1603
4 GRAPHIC g813820g57x15.jpg GRAPHIC 5793
  Complete submission text file 0001193125-19-280628.txt   93026
Mailing Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540
Business Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540 (609) 382-9032
Oyster Point Pharma, Inc. (Filer) CIK: 0001720725 (see all company filings)

IRS No.: 811030955 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-234416 | Film No.: 191184595
SIC: 2836 Biological Products, (No Diagnostic Substances)